AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutman, R. A.
Right arrow Articles by Recant, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutman, R. A.
Right arrow Articles by Recant, L.
Agricola
Right arrow Articles by Gutman, R. A.
Right arrow Articles by Recant, L.

American Journal of Clinical Nutrition, Vol 26, 165-172, Copyright © 1973 by The American Society for Clinical Nutrition, Inc.

Hypertriglyceridemia in chronic nonnephrotic renal failure

R. A. Gutman 1, A. Uy 1, R. J. Shalhoub 1, A. D. Wade 1, J. M. B. O'Connell 1, and L. Recant 1

1 From the Veterans Administration Hospital, Washington, D.C. and Georgetown University Medical School, Washington, D.C.

Elevated plasma triglyceride (TG) levels were present in 11 out of 14 undialyzed (U) patients and 17 out of 25 hemodialyzed (H) uremic patients with chronic nonnephrotic renal failure (CRF). Plasma postheparin lipolytic activity (PHLA) was strikingly reduced in 21 out of 22 patients examined in the CRF groups under study. After hemodialysis, TG fell to normal simultaneously with a significant increase in PHLA. TG and PHLA returned to predialysis values 12 to 36 hr after hemodialysis. Metabolic improvement occasioned by dialysis did not seem to be responsible for TG and PHLA changes as patients undergoing either hemodialysis on regional heparinization or peritoneal dialysis (PD) who had similar metabolic improvement showed no change in TG or PHLA. Thus, the role of heparin was investigated. The iv injection of the standard dose of heparin used for PHLA determinations produced no significant change in TG in two CRF patients as compared with a 60% drop in two normal subjects. In contrast, the iv injection of 40 mg heparin into two CRF patients resulted in more than a 50% fall in TG, accompanied by a significant rise in PHLA. No evidence for PHLA inhibitors could be found in five CRF patients tested. Our data indicate that in CRF, a quantitatively subnormal PHLA response to heparin exists and that abnormal TG clearance mechanisms may play a major role in CRF hypertriglyceridemia. In addition, sufficient caloric intake and a good nutritional status resulting in adequate TG synthesis seem to be necessary for the hypertriglyceridemia to be evident. Of the CRF patients who had normal TG levels, 75% were undernourished as compared with only 6% among the CRF patients with hypertriglyceridemia. Whatever the basic mechanisms involved in the TG and PHLA abnormalities reported here, chronic renal insufficiency is a primary component, as in one patient with a successful 7-year kidney transplant, restoration of renal function was accompanied by normal PHLA and TG levels.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by The American Society for Nutrition